The ROE as of September 2024 (TTM) for Blueprint Medicines Corporation (BPMC) is -85.25%

According to Blueprint Medicines Corporation’s latest financial reports and current stock price. The company's current ROE is -85.25%. This represents a change of 147.39% compared to the average of -34.46% of the last 4 quarters.

Blueprint Medicines Corporation (BPMC) Historical ROE (quarterly & annually)

How has BPMC ROE performed in the past?

The mean historical ROE of Blueprint Medicines Corporation over the last ten years is -87.69%. The current -85.25% ROE has changed -2.78% with respect to the historical average. Over the past ten years (40 quarters), BPMC's ROE was at its highest in in the September 2020 quarter at 48.03%. The ROE was at its lowest in in the December 2023 quarter at -84.92%.

Blueprint Medicines Corporation (BPMC) ROE by Quarter and Year

Discovering the peaks and valleys of Blueprint Medicines Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Blueprint Medicines Corporation (BPMC) Average ROE

How has BPMC ROE performed in the past?

The current ROE of Blueprint Medicines Corporation (BPMC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Blueprint Medicines Corporation (BPMC) ROE vs. Peers

How is BPMC’s ROE compared to its peers?

Blueprint Medicines Corporation’s ROE is greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Amylyx Pharmaceuticals, Inc. (-46.15%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than Inozyme Pharma, Inc. (-68.93%), less than X4 Pharmaceuticals, Inc. (32.93%), less than PTC Therapeutics, Inc. (57.03%), less than Krystal Biotech, Inc. (13.36%), greater than Intercept Pharmaceuticals, Inc. (-78.24%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than Mereo BioPharma Group plc (-63.39%), greater than IVERIC bio, Inc. (-38.66%), greater than Karuna Therapeutics, Inc. (-30.79%),

Build a custom stock screener for Blueprint Medicines Corporation (BPMC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Blueprint Medicines Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Blueprint Medicines Corporation (BPMC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Blueprint Medicines Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.